Baillie Gifford's position in Medline is currently worth $344M. That's 0.28% of their equity portfolio (62nd largest holding). The investor owns 1.11% of the outstanding Medline stock. Baillie Gifford started to build up the position in Medline in Q4 2025. Since then they sold 435k shares. The investor's estimated purchase price is $428M, resulting in a loss of 20%.